Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nick Andrews

Showing results (171-180 of 364) with videos related to

Pageof 37
Sort By:
Statistical Methods in Medical Research|October 25, 2021
Methods for modelling excess mortality across England during the COVID-19 pandemicSharmani Barnard, Chiara Chiavenna, Sebastian Fox, et al.
Clinical and Vaccine Immunology : CVI|December 19, 2008
Immunogenicity of a reduced schedule of meningococcal group C conjugate vaccine given concomitantly with the Prevenar and Pediacel vaccines in healthy infants in the United KingdomJo Southern, Ray Borrow, Nick Andrews, et al.
International Journal of Epidemiology|May 4, 2021
Interactions between SARS-CoV-2 and influenza, and the impact of coinfection on disease severity: a test-negative designJulia Stowe, Elise Tessier, H Zhao, et al.
The Journal of Infection|November 13, 2019
Variable clinical presentation by the main capsular groups causing invasive meningococcal disease in EnglandHelen Campbell, Nick Andrews, Sydel Parikh, et al.
Plos One|March 20, 2015
East London experience with enteric fever 2007-2012Jayshree Dave, Michael Millar, Horst Maxeiner, et al.
The Lancet. Infectious Diseases|June 6, 2024
Sleeper frameworks for Pathogen X: surveillance, risk stratification, and the effectiveness and safety of therapeutic interventionsSimon de Lusignan, Ting Shi, Tom Fowler, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 13, 2006
Bombesin receptors as a novel anti-anxiety therapeutic target: BB1 receptor actions on anxiety through alterations of serotonin activityZul Merali, Tania Bédard, Nick Andrews, et al.
Emerging Infectious Diseases|October 25, 2012
Seroprevalence of influenza A(H1N1)pdm09 virus antibody, England, 2010 and 2011Katja Hoschler, Catherine Thompson, Nick Andrews, et al.
The Journal of Infection|June 14, 2025
Infants of hepatitis B surface antigen positive women of Black ethnicity in the UK may be at risk of acquiring human T-cell lymphotropic virus type 1Daniel Bradshaw, Panida Silalang, Nick Andrews, et al.
Emerging Infectious Diseases|March 21, 2007
Vaccine effectiveness estimates, 2004-2005 mumps outbreak, EnglandCheryl Cohen, Joanne M White, Emma J Savage, et al.
Pageof 37

Showing results (171-180 of 364) with videos related to

Sort By:
Pageof 37
Statistical Methods in Medical Research|October 25, 2021
Methods for modelling excess mortality across England during the COVID-19 pandemicSharmani Barnard, Chiara Chiavenna, Sebastian Fox, et al.
Clinical and Vaccine Immunology : CVI|December 19, 2008
Immunogenicity of a reduced schedule of meningococcal group C conjugate vaccine given concomitantly with the Prevenar and Pediacel vaccines in healthy infants in the United KingdomJo Southern, Ray Borrow, Nick Andrews, et al.
International Journal of Epidemiology|May 4, 2021
Interactions between SARS-CoV-2 and influenza, and the impact of coinfection on disease severity: a test-negative designJulia Stowe, Elise Tessier, H Zhao, et al.
The Journal of Infection|November 13, 2019
Variable clinical presentation by the main capsular groups causing invasive meningococcal disease in EnglandHelen Campbell, Nick Andrews, Sydel Parikh, et al.
Plos One|March 20, 2015
East London experience with enteric fever 2007-2012Jayshree Dave, Michael Millar, Horst Maxeiner, et al.
The Lancet. Infectious Diseases|June 6, 2024
Sleeper frameworks for Pathogen X: surveillance, risk stratification, and the effectiveness and safety of therapeutic interventionsSimon de Lusignan, Ting Shi, Tom Fowler, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 13, 2006
Bombesin receptors as a novel anti-anxiety therapeutic target: BB1 receptor actions on anxiety through alterations of serotonin activityZul Merali, Tania Bédard, Nick Andrews, et al.
Emerging Infectious Diseases|October 25, 2012
Seroprevalence of influenza A(H1N1)pdm09 virus antibody, England, 2010 and 2011Katja Hoschler, Catherine Thompson, Nick Andrews, et al.
The Journal of Infection|June 14, 2025
Infants of hepatitis B surface antigen positive women of Black ethnicity in the UK may be at risk of acquiring human T-cell lymphotropic virus type 1Daniel Bradshaw, Panida Silalang, Nick Andrews, et al.
Emerging Infectious Diseases|March 21, 2007
Vaccine effectiveness estimates, 2004-2005 mumps outbreak, EnglandCheryl Cohen, Joanne M White, Emma J Savage, et al.
Pageof 37